I was diagnosed with Lobular Breast Cancer in November 2015. I have had two operations - mastectomy and lymph node removal - chemotherapy (FEC D - 6 treatments) and radiotherapy (15). I was hospitalised three times with sepsis while undergoing Docetaxol and reverted to Fec for final treatment. Radiotherapy on the 10/08/16 and I am now taking Anastrozole, Natecal D3 and Alendronic Acid.
My lovely Daddy passed away from secondary cancer of the bile ducts (primary unknown)/chemo induced pneumonia in March 2012 and I miss him terribly.
My Mum was diagnosed with Triple Negative Breast Cancer just before Christmas 2017. She had a mastectomy and had her lymph nodes removed (left side - in one fell swoop). She completed 15 sessions of radiotherapy (chemo was not offered due to age) and appeared to be doing well. October 31st scan showed liver lesion and tumours in lungs but no spread to bones - by 24/12/18 Mum’s bones were riddled.
31/01/19 Mummy passed away - she suffered greatly so it was a release. No more suffering and she is back 'home' with my dear Father - I thank them both for everything.
In 2020 my husband was diagnosed with bowel cancer; he had resection but because there was no nodal involvement no further treatment was required.
Had balloon dilation in January 2021 due to oesophageal stricture (could hardly eat or even keep water down for many many months) - this may have been due to taking Alendronic Acid. My Bloods were all normal in January but by May there was something seriously awry with my ALP and GGT levels - they were off the chart. I more or less knew what these levels implied . Elevated ALP levels on their own imply an issue with bones only/together both ALP and GGTs most likely liver cancer (or apparently maybe an issue with gallbladder) Anyhow, I was diagnosed two weeks ago with secondary breast cancer in liver with ‘heavy tumour burden’. Had liver biopsy last Monday to check whether receptors have remained the same as this will obviously affect treatment plan. I am hoping to start chemo this week.